Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Abbott Diabetes Care, Inc.
WARNING LETTER
•Abbott Diabetes Care, Inc.•March 5, 2010

Abbott Diabetes Care, Inc. – FDA Warning Letter, Mar 5, 2010

Record Details

On July 2, 2010, the FDA issued a Warning Letter to Ms. Heather L. Mason, President of a firm in Alameda, California, following an inspection from February 8 to March 5, 2010. The inspection revealed that the firm's FreeStyle glucose monitoring and Navigator continuous monitoring systems, classified as devices under section 201(h) of the Act, were adulterated. The manufacturing, packing, storage, or installation methods and controls did not conform to the Current Good Manufacturing Practice (CGMP) requirements of the Quality System (QS) regulation (21 CFR Part 820).

The letter detailed several violations: 1. **Failure to adequately validate processes (21 CFR 820.75(a)):** Specific quality control testing and inspection for certain lots (e.g., 0804427, 0804521, 0804624, 0811405, 0811433) were not performed as required by established procedures. The firm's response was deemed inadequate as the investigation was incomplete. 2. **Failure to verify or validate corrective and preventative actions (21 CFR 820.100(a)(4)):** Exception Reports (ERs) for issues like empty blister packs (ER (b)(4)) and

Company
Abbott Diabetes Care, Inc.
Inspection date
March 5, 2010
Product type
Devices
Office
San Francisco District Office
People
  • Lawton W. Lum (Director of Compliance Branch)
  • Barbara J. Cassens (Director )
View Company Profile

ID · 5ab9c49c-333b-41a8-97e4-0747ff4f5435

Violation Codes7
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 820.75(a)21 CFR 820.100(a)(4)21 CFR 820.30(g)21 CFR 820.25(a)21 CFR 820

Full citation text and observation details available on the Dashboard.

Other documents for Abbott Diabetes Care, Inc.
  • 483 - 2025-10-23October 23, 2025
  • WARNING_LETTER - 2025-10-23October 23, 2025
  • 483 - 2022-04-21April 21, 2022
  • 483 - 2017-12-04December 4, 2017

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Abbott Diabetes Care, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.